Status:
TERMINATED
Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section
Lead Sponsor:
Emory University
Conditions:
Respiratory Distress Syndrome, Newborn
Eligibility:
FEMALE
Phase:
PHASE2
PHASE3
Brief Summary
This is a randomized, multicenter, double blind, placebo controlled trial of betamethasone versus a placebo given prior to the mothers at term and near term gestation (\>34 and \<40 weeks of gestation...
Detailed Description
The purpose of this pilot study is to determine if antepartum betamethasone given to mothers undergoing elective cesarean section (ECS) delivery at term or near term gestation (\>34 and \< 40 weeks of...
Eligibility Criteria
Inclusion
- Pregnant women \>/= 34 weeks gestation scheduled to undergo operative delivery within 48-72 hours after study enrollment
Exclusion
- Known contraindication to the use of betamethasone in the mother
- Known lethal or non-lethal congenital anomaly diagnosed antenatally
- Spontaneous labor
- Premature rupture of membranes
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00139256
Start Date
August 1 2005
End Date
September 1 2007
Last Update
November 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University affiliated newborn intensive care units
Atlanta, Georgia, United States, 30322